Results 161 to 170 of about 29,765 (217)

Protein-losing enteropathy caused by Yersinia enterocolitica colitis

Paediatrics and International Child Health, 2021
A 7-month-old boy was admitted with acute gastro-enteritis accompanied by fever and hyponatraemic dehydration. The clinical course was complicated by severe hypokalaemia and hypo-albuminaemia with anasarca.
L. Ferreira, Raquel Amaral, Fernanda Gomes, J. Cabral   +3 more
semanticscholar   +1 more source

Protein‐losing enteropathy in the Lundehund

Journal of Small Animal Practice, 1977
ABSTRACTProtein‐losing enteropathy in the Lundehund, a possible hereditary disease, characterized clinically by intermittent diarrhoea, vomiting, wasting, ascites and oedema, is described. Serum examinations revealed low values of protein and calcium.Post‐mortem changes consisted of thickened duodenal and jejunal mucosa with blunt, short, anastomosing ...
K, Flesjå, T, Yri
openaire   +2 more sources

Giardiasis with Protein-Losing Enteropathy

Journal of Pediatric Gastroenterology and Nutrition, 1985
Generalized edema and ascites were the main presenting features of giardiasis in a 3-year-old boy. Hypoalbuminemia, jejunal villous atrophy, Giardia lamblia in the duodenal aspirate, and abnormal gastrointestinal protein loss were present before therapy with metronidazole.
D L, Sutton, K R, Kamath
openaire   +2 more sources

Cardiomyopathy with Protein-Losing Enteropathy

Chest, 1973
A patient with cardiomyopathy, severe hypoproteinemia and lymphocytopenia is described. Increased catabolic rate of plasma albumin and excessive intestinal protein loss were documented. In spite of the combined lymphocytopenia and hypoimmunoglobulinemia, the patient was not predisposed to infections.
I, Oliver, M M, Aygen, J, Pinkhas, E, Lubin, A, De Vries   +4 more
openaire   +2 more sources

Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer.

Japanese Journal of Clinical Oncology
The GLOW and SPOTLIGHT trials have demonstrated the efficacy of chemotherapy plus zolbetuximab for HER2-negative, claudin-18 isoform 2 (CLDN18.2)-positive unresectable advanced or recurrent gastric cancer (AGC)/gastroesophageal junction cancer.
Y. Yanagimoto, Kazuyoshi Yamamoto, K. Hara, Yasunori Masuike, Y. Ushimaru, Masanori Kitamura, Keiichiro Honma, Norihiro Matsuura, T. Sugase, T. Kanemura, R. Mori, Masatoshi Kitakaze, Masataka Amisaki, Masahiko Kubo, Yosuke Mukai, Hisateru Komatsu, Toshinori Sueda, Y. Kagawa, J. Nishimura, H. Wada, Kunihito Goto, M. Yasui, Takeshi Omori, H. Miyata   +23 more
semanticscholar   +1 more source

Protein‐Losing Enteropathy in a Dog

Journal of Small Animal Practice, 1969
Abstract— —A protein‐losing enteropathy in a dog is described. There was a history of chronic gastrointestinal upset and examination revealed hypoproteinaemic oedema and ascites. Antemortem laboratory findings indicated a protein‐losing enteropathy and these, together with the results of clinical and necropsy examination, are described.
B R, Farrow, R, Penny
openaire   +2 more sources

Protein-Losing Enteropathies in Dogs

Veterinary Clinics of North America: Small Animal Practice, 2011
Protein-losing enteropathy is common in dogs but rare in cats. In the vast majority of cases, it is associated with inflammatory bowel disease, intestinal lymphoma, or intestinal lymphangiectasia. The diagnosis is based on identification of hypoalbuminemia and ruling out urinary loss and liver failure.
Olivier, Dossin, Rachel, Lavoué
openaire   +2 more sources

Fontan protein‐losing enteropathy is associated with advanced liver disease and a proinflammatory intestinal and systemic state

Liver international (Print), 2020
Protein‐losing enteropathy (PLE) after Fontan surgery carries significant morbimortality. Its pathophysiology and association with other Fontan complications are poorly understood.
E. Rodríguez de Santiago, L. Téllez, Elvira Garrido-Lestache Rodríguez-Monte, E. Garrido-Gómez, L. Aguilera-Castro, M. Álvarez-Fuente, M. D. del Cerro, A. Albillos, R. Romera, A. Olavarría, J. Martínez, I. Sánchez   +11 more
semanticscholar   +1 more source

Protein-losing enteropathy and gastropathy

Current Treatment Options in Gastroenterology, 2001
The diagnosis of protein-losing enteropathy (PLE) should be considered in all patients with hypoalbuminemia and edema without other known causes, and established by plasma alpha(1)-antitrypsin (alpha(1)-AT) clearance or nuclear studies. The therapy for PLE should focus principally on the treatment of the underlying disease after it has been identified.
Brian R., Landzberg, Mark B., Pochapin
openaire   +2 more sources

Treatment strategies for protein-losing enteropathy in Fontan-palliated patients

Cardiology in the Young, 2020
Objective: Protein-losing enteropathy is an infrequent but severe condition occurring after Fontan procedure. The multifactorial pathogenesis remains unclear and no single proposed treatment strategy has proven universally successful.
Anastasia Schleiger, S. Ovroutski, B. Peters, S. Schubert, J. Photiadis, F. Berger, P. Kramer   +6 more
semanticscholar   +1 more source